AJP - GI Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 281: G1423-G1431, 2001;
0193-1857/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moulin, F.
Right arrow Articles by Roth, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moulin, F.
Right arrow Articles by Roth, R. A.
Vol. 281, Issue 6, G1423-G1431, December 2001

Hepatic and extrahepatic factors critical for liver injury during lipopolysaccharide exposure

Frederic Moulin, Bryan L. Copple, Patricia E. Ganey, and Robert A. Roth

Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan 48824

Bacterial endotoxin [lipopolysaccharide (LPS)] causes liver injury in vivo that is dependent on platelets, neutrophils [polymorphonuclear leukocytes (PMNs)], and several inflammatory mediators, including thrombin. We tested the hypothesis that thrombin contributes to LPS-induced hepatocellular injury through direct interactions with platelets and/or PMNs in vitro. Perfusion of isolated livers from LPS-treated rats with buffer containing thrombin resulted in a significant increase in alanine aminotransferase (ALT) activity in the perfusion medium, indicating hepatocellular damage. This effect was completely abolished by prior depletion of PMNs from the LPS-treated donor rats but not by depletion of platelets, suggesting interaction between thrombin and PMNs in the pathogenesis. Thrombin did not, however, enhance degranulation of rat PMNs in vitro, and it was not directly toxic to isolated rat hepatocytes in the presence of PMNs even after LPS exposure, suggesting that hepatocellular killing by the PMN-thrombin combination requires the intervention of an additional factor(s) within the liver. In livers from naive donors perfused with buffer containing PMNs and LPS, no injury occurred in the absence of thrombin. Addition of thrombin (10 nM) to the medium caused pronounced ALT release. These results indicate that thrombin and PMNs are sufficient extrahepatic requirements for LPS-induced hepatocellular damage in intact liver.

endotoxin; coagulation system; perfused liver; inflammation; necrosis; polymorphonuclear leukocyte; platelet; hepatotoxicity; neutrophil; lipopolysaccharide


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. Nitescu, E. Grimberg, S.-E. Ricksten, N. Marcussen, H. Nordlinder, and G. Guron
Effects of thrombin inhibition with melagatran on renal hemodynamics and function and liver integrity during early endotoxemia
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1117 - R1124.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
M. Duggan, D. Engelberts, R. P. Jankov, J. M. A. Worrall, R. Qu, G. M. T. Hare, A. K. Tanswell, J. B. Mullen, and B. P. Kavanagh
Hypocapnia attenuates mesenteric ischemia-reperfusion injury in a rat model: [L'hypocapnie attenue la lesion mesenterique d'ischemie-reperfusion chez un modele rat]
Can J Anesth, March 1, 2005; 52(3): 262 - 268.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. B. Yee, J. R. Harkema, P. E. Ganey, and R. A. Roth
The Coagulation System Contributes to Synergistic Liver Injury from Exposure to Monocrotaline and Bacterial Lipopolysaccharide
Toxicol. Sci., August 1, 2003; 74(2): 457 - 469.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. L. Copple, F. Moulin, U. M. Hanumegowda, P. E. Ganey, and R. A. Roth
Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused Livers
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 417 - 425.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. P. Luyendyk, B. L. Copple, C. C. Barton, P. E. Ganey, and R. A. Roth
Augmentation of Aflatoxin B1 Hepatotoxicity by Endotoxin: Involvement of Endothelium and the Coagulation System
Toxicol. Sci., March 1, 2003; 72(1): 171 - 181.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. Kinser, B. L. Copple, R. A. Roth, and P. E. Ganey
Enhancement of Allyl Alcohol Hepatotoxicity by Endotoxin Requires Extrahepatic Factors
Toxicol. Sci., October 1, 2002; 69(2): 470 - 481.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. L. Su
Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation
Am J Physiol Gastrointest Liver Physiol, August 1, 2002; 283(2): G256 - G265.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online